Analyst Actions: Covance, MedImmune Upgraded; Autodesk's Price Target Boosted - TheStreet

Deutsche Banc Alex. Brown raised its rating on Albany Molecular (AMRI) to strong buy from buy.

Credit Suisse First Boston

reinstated coverage of

Applied Micro Devices

(AMCC)

as a strong buy and set a price target of 240.

First Boston raised its six-month price target on

Autodesk

(ADSK) - Get Report

to 46.

J.P. Morgan

downgraded the rating of

Basin Exploration

(BSNX)

to market performer from buy.

First Boston analyst Wendell Laidley said that although

Brio Technology's

(BRYO)

business remains solid, he is concerned about the implications of Karen Willem's resignation as CFO of the company.

Warburg Dillon Read

upped its rating on

Covance

(CVD)

to buy from hold.

Banc of America

upped its rating on

Digital Insight

(DGIN)

to strong buy from buy.

Morgan Stanley Dean Witter

raised its rating on

Filenet

(FILE)

to outperform from neutral and set a price target of 50.

J.P. Morgan downgraded the rating of

Hartford Financial

(HIG) - Get Report

to market perform from buy.

Banc of America raised its rating on

Manugistics

(MANU) - Get Report

to strong buy from buy.

Salomon Smith Barney analyst Jack Grubman reiterated his buy rating on

MCI WorldCom

(WCOM)

.

Salomon Smith Barney upped

MedImmune's

(MEDI)

rating to buy and set a price target of 170.

Merrill Lynch

upped its intermediate-term rating on

Praxair

(PX)

to buy from neutral.

Deutsche Banc Alex.Brown

reinstated coverage of

SpectraSite Holdings

(SITE) - Get Report

with a buy rating.

First Boston upgraded

Toll Brothers

(TOL) - Get Report

to buy from hold.

J.P. Morgan cut the rating for

Travelers Property

(TAP) - Get Report

to market perform from buy.